Workday must face claims that its popular AI-powered human resources software weeded out job applicants at other companies in ...
Nara Organics recalled its organic baby formula sold nationwide in Target stores and online Saturday after a multistate outbreak of infant botulism, federal authorities said. Three babies between 2 ...
After working traditional hours for more than 20 years, John D. Connolly realized that wasn’t how he worked best. “I’d be dialed in, looking at the computer for six hours but I wouldn’t have any more ...
A new analysis of chemicals in U.S. infant formula found reassuringly low levels of heavy metals, pesticides and other potential contaminants, federal health officials said Wednesday. The review was ...
Mark Cuban said AI agents will slash an hour of work from typical workdays. In an X post on Sunday, the billionaire investor wrote that "smart, bigger companies" will let their employees create and ...
Workday built its empire on per-seat licensing, charging enterprises based on headcount. AI agents do not have seats. As companies replace human workflows with autonomous software, the per-seat model ...
Workday Inc.’s second-quarter earnings beat wasn’t enough to assuage investor fears about an ongoing downturn in the software industry. Workday WDAY reported earnings per share of $2.21 late Thursday, ...
If you have encountered the error message “There’s a problem with this formula” in Microsoft Excel, you are not alone. Many users report this error appearing ...
As one of the most heavily regulated foods on the market, infant formula is subject to strict nutrition guidelines and undergoes rigorous safety and quality testing. But CR’s tests of infant formula ...
Workday's quarterly guidance trailed consensus. The company has been caught in downward pressure on software stocks in recent weeks. CEO Carl Eschenbach stepped down earlier this month, and Aneel ...
A previous version of this story misstated the first name of Workday’s former CEO. Workday has announced that its co-founder and CEO, Carl Eschenbach, is stepping down. And investors aren’t happy ...